Structural characterization and immunomodulatory activity of an exopolysaccharide from marine-derived Aspergillus

Keyue Wu1, Yiyang Li1, Yuqi Lin2

  • 1University Joint Laboratory of Guangdong Province, Hong Kong and Macao Region on Marine Bioresource Conservation and Exploitation, College of Marine Sciences, South China Agricultural University, Guangzhou, Guangdong 510642, China.

Insights

Marine fungus Aspergillus versicolor SCAU141 yielded exopolysaccharide AVP141-A. This sulfated polysaccharide activates immune responses by modulating inflammatory pathways and amino acid metabolism, showing potential as an immune activator.

Area of Science:

  • Marine microbiology
  • Immunology
  • Biochemistry

Background:

  • Limited knowledge exists on marine-derived fungal polysaccharides and their biological activities.
  • Marine fungi represent a promising source of novel bioactive compounds.

Purpose of the Study:

  • To isolate and characterize a novel exopolysaccharide (AVP141-A) from the marine fungus Aspergillus versicolor SCAU141.
  • To investigate the structural features and immunomodulatory effects of AVP141-A.

Main Methods:

  • Isolation and purification using chromatography techniques (Diethylaminoethyl-Sepharose Fast Flow, Sephadex G-100).
  • Structural elucidation via chemical analysis, HPLC, IC, FTIR, GC-MS, and NMR spectroscopy.
  • Assessment of immunomodulatory activity in RAW264.7 macrophages, including pathway analysis (MAPK/p38, NF-κB/p65) and metabolomics.

Main Results:

  • AVP141-A is a sulfated exopolysaccharide (3.62% sulfate) with a molecular weight of 5.10 kDa, primarily composed of α-D-glucan.
  • AVP141-A significantly enhanced inflammatory factors (NO, COX-2, TNF-α) in macrophages by activating MAPK/p38 and NF-κB/p65 pathways.
  • Metabolomic analysis indicated significant alterations in amino acid-related pathways, with arginine identified as a characteristic metabolite.

Conclusions:

  • AVP141-A is a novel marine fungus-derived sulfated exopolysaccharide.
  • AVP141-A exhibits potent immunomodulatory properties, acting as an immune activator.
  • AVP141-A holds potential for development as a therapeutic agent for immune system modulation.

Related Concept Videos